TrialMolecular therapy : the journal of the American Society of Gene Therapy2024

α-L-iduronidase fused with humanized anti-human transferrin receptor antibody (lepunafusp alfa) for mucopolysaccharidosis type I: A phase 1/2 trial.

Paul Harmatz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.